SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-028614
Filing Date
2016-11-09
Accepted
2016-11-09 16:06:19
Documents
47
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cala-10q_20160930.htm 10-Q 1494154
2 EX-31.1 cala-ex311_7.htm EX-31.1 13925
3 EX-31.2 cala-ex312_8.htm EX-31.2 13888
4 EX-32.1 cala-ex321_9.htm EX-32.1 6712
5 EX-32.2 cala-ex322_6.htm EX-32.2 6943
  Complete submission text file 0001564590-16-028614.txt   4673258

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cala-20160930.xml EX-101.INS 1089051
7 XBRL TAXONOMY EXTENSION SCHEMA cala-20160930.xsd EX-101.SCH 26405
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cala-20160930_cal.xml EX-101.CAL 30170
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cala-20160930_def.xml EX-101.DEF 54183
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20160930_lab.xml EX-101.LAB 205009
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20160930_pre.xml EX-101.PRE 151004
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36644 | Film No.: 161984245
SIC: 2834 Pharmaceutical Preparations